Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cellular Signalling|February 21, 2021
Biased agonism at adenosine receptorsSamantha M McNeill, Jo-Anne Baltos, Paul J White, et al.
Purinergic Signalling|July 23, 2022
Adenosine receptor signalling in Alzheimer's diseasePhuc N H Trinh, Jo-Anne Baltos, Shane D Hellyer, et al.
Biochemical Pharmacology|November 20, 2015
Quantification of adenosine A(1) receptor biased agonism: Implications for drug discoveryJo-Anne Baltos, Karen J Gregory, Paul J White, et al.
British Journal of Pharmacology|April 22, 2018
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonismElizabeth A Vecchio, Jo-Anne Baltos, Anh T N Nguyen, et al.
Frontiers in Endocrinology|July 12, 2023
Small molecule allosteric modulation of the adenosine A1 receptorAnh T N Nguyen, Quan L Tran, Jo-Anne Baltos, et al.
Biochemical Pharmacology|March 28, 2017
Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonismJo-Anne Baltos, Elizabeth A Vecchio, Matthew A Harris, et al.
Molecular Pharmacology|May 4, 2016
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 ReceptorJo-Anne Baltos, Silvia Paoletta, Anh T N Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2014
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonistCeline Valant, Lauren T May, Luigi Aurelio, et al.
Chembiochem : a European Journal of Chemical Biology|May 22, 2024
Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 ReceptorChina M Payne, Jo-Anne Baltos, Monica Langiu, et al.
Biochemical Pharmacology|August 14, 2016
The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signallingElizabeth A Vecchio, Chung Hui Chuo, Jo-Anne Baltos, et al.
Pageof 2